Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies. These challenges often center on intellectual property (IP) risks, licensing...more
1/15/2025
/ Acquisitions ,
Artificial Intelligence ,
Documentation ,
Due Diligence ,
Innovation ,
Intellectual Property Protection ,
IP License ,
Life Sciences ,
Mergers ,
Patents ,
Pharmaceutical Industry ,
Risk Management ,
Startups